New Detailed Phase 3 Data Show Amgen's Novel Investigational Cholesterol-Lowering Medication Evolocumab Significantly Reduced LDL Cholesterol In Patients With A Rare And Serious Genetic Disorder That Causes High Cholesterol Read more about New Detailed Phase 3 Data Show Amgen's Novel Investigational Cholesterol-Lowering Medication Evolocumab Significantly Reduced LDL Cholesterol In Patients With A Rare And Serious Genetic Disorder That Causes High Cholesterol
Amgen Highlights Phase 2 Results Of Vectibix® (panitumumab) Versus bevacizumab In Combination With FOLFOX In Patients With Wild-Type RAS (KRAS And NRAS) Metastatic Colorectal Cancer Read more about Amgen Highlights Phase 2 Results Of Vectibix® (panitumumab) Versus bevacizumab In Combination With FOLFOX In Patients With Wild-Type RAS (KRAS And NRAS) Metastatic Colorectal Cancer
Amgen To Present At The Jefferies 2014 Global Healthcare Conference Read more about Amgen To Present At The Jefferies 2014 Global Healthcare Conference
Amgen To Host Post-American Society of Clinical Oncology (ASCO) Summary Webcast Read more about Amgen To Host Post-American Society of Clinical Oncology (ASCO) Summary Webcast
Amgen and Onyx Data at ASCO 2014 Highlight Oncology Pipeline and Portfolio Read more about Amgen and Onyx Data at ASCO 2014 Highlight Oncology Pipeline and Portfolio
FDA Approves First-Line Use of Vectibix® (Panitumumab) Plus FOLFOX for Patients with Wild-Type KRAS Metastatic Colorectal Cancer Read more about FDA Approves First-Line Use of Vectibix® (Panitumumab) Plus FOLFOX for Patients with Wild-Type KRAS Metastatic Colorectal Cancer
The New England Journal Of Medicine Publishes Positive Proof-Of-Concept Data For New Asthma Treatment Read more about The New England Journal Of Medicine Publishes Positive Proof-Of-Concept Data For New Asthma Treatment
Amgen Announces Voting Results of Annual Meeting of Stockholders Read more about Amgen Announces Voting Results of Annual Meeting of Stockholders
Journal Of The American Medical Association Publishes Phase 3 LAPLACE-2 Study Showing Evolocumab Significantly Reduced LDL Cholesterol In Patients On Statins Regardless Of Statin Dose Read more about Journal Of The American Medical Association Publishes Phase 3 LAPLACE-2 Study Showing Evolocumab Significantly Reduced LDL Cholesterol In Patients On Statins Regardless Of Statin Dose
Amgen's Breakaway from Cancer® Honors Four California Cancer Survivors During The Ninth Annual Amgen Tour of California Read more about Amgen's Breakaway from Cancer® Honors Four California Cancer Survivors During The Ninth Annual Amgen Tour of California
